Vivencio Vicente
Barrios Alonso
Profesor/a Asociado/a en CC. de la Salud
University of Liverpool
Liverpool, Reino UnidoPublikationen in Zusammenarbeit mit Forschern von University of Liverpool (4)
2022
-
Correction to: Effectiveness and Safety of Dabigatran Compared to Vitamin K Antagonists in Non‑Asian Patients with Atrial Fibrillation: A Systematic Review and Meta‑Analysis (Clinical Drug Investigation, (2021), 41, 11, (941-953), 10.1007/s40261-021-01091-w)
Clinical Drug Investigation
-
Predicting performance of the HAS-BLED and ORBIT bleeding risk scores in patients with atrial fibrillation treated with Rivaroxaban: Observations from the prospective EMIR Registry
European heart journal. Cardiovascular pharmacotherapy, Vol. 9, Núm. 1, pp. 38-46
2021
-
A new index to predict quality of anticoagulation control in patients on vitamin K antagonists: The DAFNE score
Future Cardiology, Vol. 17, Núm. 4, pp. 685-692
-
Effectiveness and Safety of Dabigatran Compared to Vitamin K Antagonists in Non-Asian Patients with Atrial Fibrillation: A Systematic Review and Meta-Analysis
Clinical Drug Investigation, Vol. 41, Núm. 11, pp. 941-953